Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects. A randomized, double-blind placebo-controlled clinical trial.

A.A. van Everdingen; J.W.G. Jacobs; D.R. Siewertsz van Reesema

Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects. A randomized, double-blind placebo-controlled clinical trial.

Translated title of the contribution: Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects. A randomized, double-blind placebo-controlled clinical trial.

A.A. van Everdingen
, J.W.G. Jacobs
, D.R. Siewertsz van Reesema

Rheumatology & Clinical Immunology

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Professional

Translated title of the contribution	Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects. A randomized, double-blind placebo-controlled clinical trial.
Original language	Undefined/Unknown
Title of host publication	The year book of rheumatology, arthritis, and musculoskeletal disease.
Editors	RS Panush
Place of Publication	Philadelphia: Mosby
Pages	53-55
Number of pages	3
Publication status	Published - 2003

Cite this

van Everdingen, A. A., Jacobs, J. W. G., & Siewertsz van Reesema, D. R. (2003). Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects. A randomized, double-blind placebo-controlled clinical trial. In RS. Panush (Ed.), The year book of rheumatology, arthritis, and musculoskeletal disease. (pp. 53-55).

van Everdingen, A.A. ; Jacobs, J.W.G. ; Siewertsz van Reesema, D.R. / Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects. A randomized, double-blind placebo-controlled clinical trial. The year book of rheumatology, arthritis, and musculoskeletal disease.. editor / RS Panush. Philadelphia: Mosby, 2003. pp. 53-55

@inbook{f0bfb5e23c8f4b1cb7cfa742e555a749,

title = "Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects. A randomized, double-blind placebo-controlled clinical trial.",

author = "\{van Everdingen\}, A.A. and J.W.G. Jacobs and \{Siewertsz van Reesema\}, D.R.",

year = "2003",

language = "Undefined/Unknown",

pages = "53--55",

editor = "RS Panush",

booktitle = "The year book of rheumatology, arthritis, and musculoskeletal disease.",

}

van Everdingen, AA, Jacobs, JWG & Siewertsz van Reesema, DR 2003, Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects. A randomized, double-blind placebo-controlled clinical trial. in RS Panush (ed.), The year book of rheumatology, arthritis, and musculoskeletal disease.. Philadelphia: Mosby, pp. 53-55.

Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects. A randomized, double-blind placebo-controlled clinical trial. / van Everdingen, A.A.; Jacobs, J.W.G.; Siewertsz van Reesema, D.R.
The year book of rheumatology, arthritis, and musculoskeletal disease.. ed. / RS Panush. Philadelphia: Mosby, 2003. p. 53-55.

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Professional

TY - CHAP

T1 - Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects. A randomized, double-blind placebo-controlled clinical trial.

AU - van Everdingen, A.A.

AU - Jacobs, J.W.G.

AU - Siewertsz van Reesema, D.R.

PY - 2003

Y1 - 2003

M3 - Chapter

SP - 53

EP - 55

BT - The year book of rheumatology, arthritis, and musculoskeletal disease.

A2 - Panush, RS

CY - Philadelphia: Mosby

ER -

van Everdingen AA, Jacobs JWG, Siewertsz van Reesema DR. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects. A randomized, double-blind placebo-controlled clinical trial. In Panush RS, editor, The year book of rheumatology, arthritis, and musculoskeletal disease.. Philadelphia: Mosby. 2003. p. 53-55